InveniAI

InveniAI is a global leader, pioneering the application of artificial intelligence (AI) and machine learning (ML) to drive innovation in drug discovery by identifying and accelerating transformative therapies for diseases with unmet medical needs. The company leverages AI and ML to harness the value of AI-based drug discovery and development using diverse datasets spanning several petabytes. Utilizing the AlphaMeld® platform, the company generates drug candidates for industry partners and its internal drug portfolio.